Related Experiment Video
Updated: Jun 26, 2026

04:23
A Treatment Package without Escape Extinction to Address Food Selectivity
Published on: August 21, 2015
11.5K
ARFID Parent Training Protocol ("ARFID-PTP"): Results of a Randomized Pilot Trial Evaluating a Brief, Parent-Training
Courtney E Breiner1,2, McKenzie L Miller2, Julia M Hormes2
1Department of Psychiatry, Columbia University Irving Medical Center, New York, New York, USA.
The International Journal of Eating Disorders
|July 20, 2024
Summary
A brief virtual intervention for avoidant/restrictive food intake disorder (ARFID) in children is acceptable and effective. This ARFID-PTP program shows promise for improving children's eating behaviors and reducing symptoms.
Area of Science:
- Pediatric Psychology
- Child Psychiatry
- Clinical Psychology
Background:
- Avoidant/Restrictive Food Intake Disorder (ARFID) presents limited accessible treatment options for children.
- The need for effective, scalable interventions for pediatric ARFID is critical.
Purpose of the Study:
- To assess the acceptability, feasibility, and preliminary efficacy of a brief, virtual intervention for ARFID in children, termed ARFID-PTP.
- To evaluate the impact of ARFID-PTP on symptom reduction and food incorporation in pediatric patients.
Main Methods:
- A randomized controlled trial involving 30 children (ages 5-12) with ARFID, assigned to immediate or waitlist treatment groups.
- ARFID-PTP comprised two 2-hour virtual sessions with an optional booster, with data collected at multiple follow-up points.
- Acceptability, feasibility, and preliminary efficacy measures were assessed throughout the study.
Main Results:
- High acceptability (M CEQ-C=7.75) and feasibility by participant retention (90%) were observed.
- The immediate treatment group showed a decrease in ARFID symptoms compared to the waitlist group.
- At 6-month follow-up, significant ARFID symptom reduction was noted, with completers incorporating an average of eight new foods.
Conclusions:
- The ARFID-PTP virtual intervention is acceptable and demonstrates preliminary efficacy in treating pediatric ARFID.
- While modifications may enhance feasibility, the intervention shows significant utility in reducing symptoms and improving dietary range.
- Further research is warranted to confirm efficacy in diverse populations requiring accessible ARFID treatments.

